Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
24 results
D1.202 - Small-Spotted Catshark Parvalbumin Sensitization in Fish-Allergic Patients
D1.203 - Pine Nut Allergy in a Pediatric Patient with Multiple Sensitizations to Tree Nuts and Storage Proteins
D1.204 - Pea-ling Back the Layers: A Systematic Review of Pea Allergies
D1.205 - Characterization of a cohort of fish allergic portuguese patients
D1.206 - A 50-year history of IgE-mediated hypersensitivity reactions to Saccharomyces cerevisiae presenting with respiratory symptoms
D1.207 - “Do nut know what: What is the current role of the prick test and serum IgE in the diagnosis of walnut allergy?
D1.208 - Clinical relevance of food allergen families
D1.209 - Pollen and Food Non-Specific Lipid Transfer Proteins: Clinical Presentations and Sensitization Profiles in a Mediterranean Population
D1.210 - Effects of Omalizumab on Human Basophils in Children with Cow’s Milk Protein Allergy
D1.212 - IgE mediated allergic reaction to rice
D1.213 - Exercise-Induced Anaphylaxis in a 18-Year-Old Woman with Egg Allergy and Potential Bird-Egg Syndrome
D1.214 - Food Allergy:Even in doubt, Challenge Test
D2.351 - Relapse Rate and Risk Factors After Omalizumab Treatment in Adolescents with Chronic Spontaneous Urticaria
D2.352 - Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria
D2.353 - A Single Dose of Briquilimab, An Anti-Human CD117 (c-Kit) Antibody, Protects Against Relapse of Epicutaneous Allergen-Induced Dermatitis in Mice Expressing Chimeric Human/Mouse CD117
D2.354 - Questionnaire survey of new treatments for atopic dermatitis
D2.355 - Concurrent use of dupilumab and omalizumab in severe atopic dermatitis and severe chronic urticaria
D2.356 - Real-life effectiveness of omalizumab and its impact on quality of life in patients with chronic spontaneous urticaria
D2.357 - Characterizing chronic histaminergic angioedema and chronic urticaria with angioedema, a multicenter Italian experience
D2.358 - Immune shift toward the IL-17 pathway: A case of paradoxical psoriasis in a patient with severe atopic dermatitis induced by dupilumab
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download